Jiangbin Ye

Title: Innovations in Cancer Treatment by Jiangbin Ye

Introduction

Jiangbin Ye is a prominent inventor based in Stanford, CA, known for his significant contributions to cancer treatment methodologies. With a total of two patents to his name, Ye's work focuses on enhancing the effectiveness of cancer therapies through innovative approaches.

Latest Patents

One of Jiangbin Ye's latest patents is titled "Sensitization of cancer cells to differentiation therapy with mitochondrial uncoupler niclosamide ethanolamine." This patent outlines methods for treating cancer by administering a mitochondrial uncoupler in a dose effective to increase the differentiation of cancer cells. The treatment may be combined with retinoic acid to enhance the effect on targeted cancer cells, particularly those resistant to retinoic acid. Another notable patent is "Treatment of cancer with combinations of agents," which provides methods for administering a combination of metabolic interventions to differentiate cancer cells. This approach also aims to enhance the effect on targeted cancer cells compared to regimens using a single agent.

Career Highlights

Jiangbin Ye is affiliated with Leland Stanford Junior University, where he conducts research and develops innovative cancer treatment strategies. His work has garnered attention for its potential to improve patient outcomes in cancer therapy.

Collaborations

Some of Jiangbin Ye's notable coworkers include Yang Li and Haowen Jiang, who collaborate with him on various research projects aimed at advancing cancer treatment methodologies.

Conclusion

Jiangbin Ye's innovative patents and research at Leland Stanford Junior University represent significant advancements in the field of cancer treatment. His work continues to inspire new approaches to combat this challenging disease.